The DISRUPT Framework: AI in Drug Discovery
‘The DISRUPT Framework’ is a quarterly exploration of artificial intelligence (AI), its profound impact on the world, and investment opportunities. Each edition will highlight investable ideas by exploring the intersection of AI and emerging technologies which shape their respective industries.
In this report on AI in Drug Discovery Global X offers three key takeaways.
- AI in drug discovery is in the “Developing” stage, showing strong potential and significant progress in disruption, resilience, and innovation.
- While it has achieved many breakthroughs, especially in speeding up the discovery process and improving clinical trials, it is still developing in terms of scalability, uptake, and realising its full potential.
- The next signal for moving forward will be broader adoption across late-stage trials and greater scalability across therapeutic areas.
Read the full report here.